• Raptiva®
• Raptiva® Lawyer
• Raptiva® Side Effects
• Progressive Multifocal Leukoencephalopathy
• Raptiva® Deaths
• Raptiva® Viral Infections
• Raptiva® Warnings
• Raptiva® Injections
• Raptiva® Medication & Dosing
• Raptiva® Infections
• Raptiva® Prescription
• Raptiva® Efalizumab
• Raptiva® Genentech
• Raptiva® Psoriasis
• Raptiva® Recall
• Raptiva® Lawsuit
• Raptiva® Attorney

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Raptiva lawsuits are personal injury cases in which patients injured after taking the psoriasis drug known as Raptiva seek compensation for their injuries.

First approved by the FDA in 2003, Raptiva is an immunosuppressant drug that treats the red, scaly patches of skin associated with psoriasis. Raptiva, which is generically known as efalizumab, is made and distributed by Genentech.

Raptiva Lawsuits: Based on Injuries

Despite its effectiveness, however, Raptiva is known to cause a range of serious, potentially fatal side effects, including:

• lymphoma
• meningitis, a viral infection marked by swelling of the brain and/or spinal cord
• progressive multifocal leukoencephalopathy (PML), a rare brain infection in which a virus causes inflammation of the brain's white matter
• sepsis, a blood infection

Raptiva patients who develop any of the above conditions, as well as families of deceased Raptiva patients, will be entitled to compensation for their injuries and losses by pursuing a Raptiva lawsuit.

Raptiva Recalls and Withdrawal from the U.S. Market

As reports of patient injuries and deaths following Raptiva use mounted, the FDA issued two nationwide Raptiva warnings:

• On October 16, 2008, the FDA required that Genentech include "black box" warning labels, the most serious type of FDA warning, on Raptiva's packaging.
  
• On February 19, 2009, the FDA announced, via a public health advisory, that three individuals had died due to Raptiva complications.

The FDA has never issued a Raptiva recall.

However, on April 8, 2009, Genentech announced that it is voluntarily withdrawing Raptiva from U.S. markets. Over a two-month period, Genentech will slowly make Raptiva unavailable for sale in the U.S.

This prolonged withdrawal period is scheduled to allow doctors and Raptiva patients to work together to find a suitable alternative psoriasis drug.

How to Start a Raptiva Lawsuit

Prospective plaintiffs can find out if they have a claim against Genentech by meeting with a Raptiva lawyer for a free initial consultation. During this meeting, Raptiva attorneys will:

• Evaluate injured parties' claims.
• Give estimates of possible settlement amounts based on past awards in similar cases.
• Inform clients about the process associated with compiling and winning Raptiva lawsuits.
• Advise plaintiffs on the best manner in which to proceed with their case.

Those who follow through with Raptiva lawsuits can win compensation for their:

• funeral and burial costs
• past hospital bills
• ongoing treatment costs
• lost wages, lost ability to work
• permanent disabilities and disfigurement
• future costs of living (should permanent disabilities prevent injured parties from earning a living)
• emotional pain and suffering

Have you or a loved one been injured after taking Raptiva? If so, contact us to talk to an experienced Raptiva lawyer will investigate the details of your injury to determine if you are eligible to file a Raptiva lawsuit and seek out compensation for your injuries.

"Raptiva side effect PML"

The U.S. Food and Drug Administration (FDA) announced a voluntary Raptiva recall, April 8, 2009. The Psoriasis drug’s manufacturer, Genentech, announced the voluntary Raptiva recall and has begun phasing the drug off the U.S. market. R...

» Read More